← Open Payments lookup

ADAM SKY: Open Payments

NPI 1346388667 · CREVE COEUR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$130,869 in 285 payments from 16 companies in 2025. Trend: 2023 $197,349 · 2024 $218,592 · 2025 $130,869

Speaker / faculty: $110,152Travel & lodging: $15,342Food & beverage: $4,704Consulting: $560Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.108$87,423
Otsuka America Pharmaceutical, Inc.83$41,907
Vanda Pharmaceuticals Inc.15$244
ABBVIE INC.14$241
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$219
Lundbeck LLC15$217
E.R. Squibb & Sons, L.L.C.15$194
Lilly USA, LLC5$97
Axsome Therapeutics, Inc.4$69
Neurocrine BioSciences, Inc.3$65

Products named: AUSTEDO XR, REXULTI, UZEDY, FANAPT, VRAYLAR, CAPLYTA, COBENFY, KISUNLA.

Industry payments across MO — which companies pay providers there.